Skip to content
2 Minute Read

eSource makes the eCRF reliable, accurate and timely

eSource makes the eCRF reliable

Bridging the gap

eSource is the bridge between the protocol and the eCRF fields. To understand why, we need to understand what each does.

The protocol describes the purpose of the study, the core hypotheses, the endpoints that are to be collected, and the resulting procedures to be performed to support those endpoints. The eCRF then translates a subset of those endpoints (i.e., the ones collected by the research site) into target data fields to be completed by site personnel.

While the eCRF is a distillation of the key fields required for analysis, it does not cover all the specifications of the protocol. This is because the protocol specifies not only the target endpoints, but also the workflows that support those endpoints.

For instance, the protocol may specify that vitals are to be taken when the patient has been in sitting position for 5 minutes, and that the same arm is to be used throughout. These specifications ensure that blood pressure readings are done in a consistent manner, so that measurements can be compared across time, with less risk of confounding factors.

However, the eCRF usually includes only the diastolic and systolic measurements, and excludes those other data points regarding how the vitals were taken. Instead, those data fields are usually captured by research sites on their source forms, with subsequent review by the CRA to ensure compliance.

eSource – Critical to following the protocol

This is where eSource comes in. eSource translates the protocol into an actionable, logically sequenced series of visits and procedures that serve as a workflow tool for the research team. For instance, well written eSource will contain detailed and pop-up instructions to clarify requirements; branching logic to guide the team down the appropriate workflow path; and alerts and edit checks not only to flag inappropriate values but also action items, such as the need to re-educate patients or to document deviations.

eSource, therefore, is critical to ensure that sites are following the protocol, capturing not just the data necessary to populate the eCRF’s, but also ensuring that the data is captured in the manner the protocol requires. From a data management perspective, eSource makes the eCRF data reliable, in that the data is meaningful and comparable across sites and subjects. This is different, and in addition to, the data being accurate and contemporaneous.

Introducing the CRIO Model – CRIO eSource/EDC 

With either CRIO’s eSource/EDC all-in-one solution or with our eSource to EDC integration (where CRIO’s eSource automatically populates the eCRF fields directly into the EDC), we give data managers immediate access to the data, with no need for data transcription by the sites into EDC or for manual source data verification.

Thus, eSource is a very powerful lever for sponsors. It enforces protocol compliance and makes the data in EDC Attributable, Legible, Contemporaneous, Original, and Accurate (ALCOA) – the gold standard for clinical data.

Discover CRIO eSource/EDC.

RaymondNomizu by Raymond Nomizu CEO at CRIO
Share this post
You may also find interesting
Explore our Blog
JSCDM Header
CRIO Company News
1 Minute Read -

JSCDM: Comparison of electronic health records and electronic source data in clinical research trials

The Journal of the Society for Clinical Data Management (JSCDM) recently published the original research article “Comparison of electronic health records and electronic source data in clinical research trials: a retrospective review” which was co-authored by Amelia Tian, CRIO Solutions Consultant, and Olivia Dennis, CRIO Analytics and Data Migration Manager, alongside Dr. Elena Christofides (Endocrinology...

21 cfr compliance update
Running a Site
5 Minute Read -

21 CFR Part 11 Regulation Compliance Update

Compliance Update:  The 21 CFR Part 11 Regulation is a cornerstone of conducting clinical trials in today’s world.  The release of the regulation 1997 established guidelines for the use of electronic records and electronic signatures in FDA-regulated industries and had a significant impact on the pharmaceutical and medical device industries. The FDA began working on...

Get articles delivered to your inbox, every week